MMJ Recs

MAY 9, 2024

The proposed legislation seeks to amend existing laws and policies to allow VA healthcare providers to discuss medical marijuana with patients, conduct research on its efficacy, and prescribe medical cannabis in states where it is legal. Any questions related to research can be addressed to VHABLRD-CSRD@va.gov.

Research and Development

MMJ Recs

AUGUST 1, 2024

While antiretroviral therapy (ART) has transformed HIV/AIDS from a fatal diagnosis to a manageable chronic condition, patients often endure chronic pain, nausea, appetite loss, and psychological distress. As such, patients report reduced reliance on opioids and other pain medications, which often come with severe side effects.

Patients

MMJ Recs

JULY 5, 2024

Medical Uses of THC Let’s explore the diverse medical uses of THC, highlighting its efficacy in alleviating chronic pain, its comparison with traditional painkillers, its role in combating nausea and stimulating appetite, its potential benefits for neurological disorders, and its complex interaction with mental health conditions.

THC

MMJ Recs

DECEMBER 22, 2023

Studies have shown the efficacy of medical cannabis in treating conditions such as chronic pain, epilepsy, and certain mental health disorders. One significant factor is the recognition of the opioid crisis and the need for alternative pain management strategies.

Marijuana

The Joint Blog

OCTOBER 21, 2020

Due to the updated hemp act being relatively new, lawmakers are still studying and formulating policies that can better improve the industry while regulating it for the safety of users. Namely, to relieve chronic pains, soothe anxiety, lessen nausea, and even aid them in sleeping better. Where Can I Buy CBD Online?

CBD

Cannabis Law Report

JUNE 9, 2022

The bill would expand patients’ access to the necessary treatment for more than 50 conditions, including cancer and post-traumatic stress disorder (PTSD), neurological diseases, and chronic pain of neuropathic origin. “; 4) Article 11 shall be worded as follows: ” Article 11. .”;

Seed-To-Sale

Cannabis Law Report

JULY 15, 2019

ACM takes in consideration the characteristics of medical cannabis preparations and substances, and is a simplified version of the marketing authorization required for medicinal products to some extent (for instance, no clinical trials are required). Author: João Taborda da Gama. 351 914 725 808. joao.gama@gamagloria.com.

Medicine

Cannabis Law Report

JUNE 30, 2019

Although the amendments represent an unprecedented level of support for pro-cannabis policies in the House, a similar level of support in the Republican-controlled Senate is unlikely. The Federal Aviation Administration issued a bulletin clarifying its cannabis and CBD policy for pilots.

Chronic Pain

Cannabis Law Report

NOVEMBER 24, 2021

Chronic pain or pain were the conditions most frequently mentioned in articles about cannabis, followed by epilepsy, cancer or cancer pain, and nausea and chemotherapy. Pain and chronic pain were the most common conditions mentioned over the time period and were referred to in 62% of all articles.

Research and Development

Veriheal

JANUARY 5, 2023

These effects were not majorly modulated by CBD, regardless of the dosage—a discovery that the study authors say should be considered in future health policy and safety decisions. The post Clinical Trial Explores CBD’s Influence on Cannabis Safety appeared first on Cannabis Central. Gaia Herbs Hemp, and Joy Organics.

Clinical Trials

Weedistry

FEBRUARY 4, 2019

One of the most common arguments against the efficacy of medical cannabis today is that public policy is outpacing real science. Just because we don’t yet have clinical trial results that confirm medical cannabis relieves pain, or eases insomnia, or reduces inflammation, etc., That’s simply not true.

Clinical Trials

Cannabis Law Report

APRIL 10, 2019

MP Philippa Whitford (representing Central Ayrshire ), a doctor, called for more support for clinical trials so that doctors will be more willing to prescribe medical cannabis products: “That is quite scary for doctors, particularly as if it is an unlicensed drug, they have to sign a form to say that they accept personal liability.

Clinical Trials

The Cannigma

MARCH 12, 2021

We’re not going to get over the fact that there’s not the same sort of clinical trial and that type of evidence for cannabis and cannabis treatments in the very near future for various reasons. There’s the one drug, one target, cannabis is multiple active ingredients and acts on multiple targets in the body.

Legalization

Cannabis Law Report

DECEMBER 30, 2019

After this historically successful year, we expect to see public and political support continue to increase in 2020 as more and more states implement sensible cannabis regulatory policies. “Never before in American history has marijuana policy advanced in Congress as far or as fast in one year as 2019. Erik Altieri.

Legislation

Cannabis Law Report

AUGUST 30, 2019

The National Institute on Drug Abuse published a grant notice to encourage research on the effects of changing US cannabis laws and policies on public health. Iowa’s Medical Cannabidiol Board formally approved a measure to add chronic pain to the list of conditions that qualify a patient for medical cannabis.

Banking

Cannabis Law Report

OCTOBER 17, 2019

Some of the potential health benefits associated with THC and CBD, with and without the high, respectively, include reducing chronic pain such as from migraines or cancer, alleviating anxiety, reducing inflammation, and helping treat conditions such as epilepsy, PTSD, and glaucoma.

Law

NORML

JANUARY 28, 2019

Presidents Barack Obama and Donald Trump have voiced support for state governments deciding their own policies. The National Center for Biotechnology Information has summarized a group of FDA approved randomized clinical trials, finding evidence for cannabis as medicine. So, in seven years why hasn’t Kentucky moved forward?

Data

Veriheal

NOVEMBER 7, 2024

This shift in federal drug policy would allow cannabis-derived drugs to be legally available by prescription, making the drug more accessible to patients and medical researchers. drug policy and public opinion regarding cannabis’ status as a medicine. Looking Ahead: The Future of U.S.

DEA